Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The oxysterol receptor GPR183 in inflammatory bowel diseases.
Misselwitz B, Wyss A, Raselli T, Cerovic V, Sailer AW, Krupka N, Ruiz F, Pot C, Pabst O. Misselwitz B, et al. Among authors: krupka n. Br J Pharmacol. 2021 Aug;178(16):3140-3156. doi: 10.1111/bph.15311. Epub 2021 Jan 12. Br J Pharmacol. 2021. PMID: 33145756 Free article. Review.
Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
Ledergerber M, Lang BM, Heinrich H, Biedermann L, Begré S, Zeitz J, Krupka N, Rickenbacher A, Turina M, Greuter T, Schreiner P, Roth R, Siebenhüner A, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Ledergerber M, et al. Among authors: krupka n. BMC Gastroenterol. 2021 Feb 5;21(1):53. doi: 10.1186/s12876-021-01622-x. BMC Gastroenterol. 2021. PMID: 33546600 Free PMC article.
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
Jordi SBU, Botte F, Lang BM, Greuter T, Krupka N, Auschra B, Schreiner P, Sulz MC, Biedermann L, von Känel R, Rogler G, Begré S, Misselwitz B; Swiss IBD cohort study group. Jordi SBU, et al. Among authors: krupka n. Aliment Pharmacol Ther. 2021 Jul;54(1):53-67. doi: 10.1111/apt.16365. Epub 2021 May 11. Aliment Pharmacol Ther. 2021. PMID: 33975385
Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease.
Jordi SBU, Lang BM, Auschra B, von Känel R, Biedermann L, Greuter T, Schreiner P, Rogler G, Krupka N, Sulz MC, Misselwitz B, Begré S; Swiss IBD Cohort Study Group. Jordi SBU, et al. Among authors: krupka n. Inflamm Bowel Dis. 2022 Mar 30;28(4):560-571. doi: 10.1093/ibd/izab136. Inflamm Bowel Dis. 2022. PMID: 34096587
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis.
Siebenhüner AR, Rossel JB, Schreiner P, Butter M, Greuter T, Krupka N, Jordi SBU, Biedermann L, Rogler G, Misselwitz B, von Känel R. Siebenhüner AR, et al. Among authors: krupka n. Therap Adv Gastroenterol. 2021 Aug 31;14:17562848211033763. doi: 10.1177/17562848211033763. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34484421 Free PMC article.
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Perrig K, Krupka N, Jordi SBU, Rossel JB, Biedermann L, Greuter T, Schreiner P, Vavricka SR, Juillerat P, Burri E, Zimmermann D, Maillard MH, Sulz MC, Brand S, Rogler G, Misselwitz B. Perrig K, et al. Among authors: krupka n. Therap Adv Gastroenterol. 2022 Feb 9;15:17562848221074188. doi: 10.1177/17562848221074188. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35154389 Free PMC article.
27 results